Product Information
EVEROLIMUS 5 MG TABLET is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $14.7708 per EA under NDC 00054048113. Its NADAC has been published 101 times since Sep 18, 2024.
FDA first approved this application on Jun 8, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054048113
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
4/22/2026
Active Ingredients
EVEROLIMUSApproval Type
Generic (ANDA)
FDA Application
ANDA207486FDA Approved
6/8/2020
TE Code
AB
On Market Since
6/8/2020
Pharmacological Classes
Price Statistics
The NADAC for EVEROLIMUS 5 MG TABLET has been published 101 times since Sep 18, 2024, and over the history we have for it it has declined 27.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $14.7708 per EA |
|---|---|
| All-time high | $23.3127 (Jan 15, 2025) |
| All-time low | $14.7708 (Dec 17, 2025) |
| 52-week high | $17.5117 |
| 52-week low | $14.7708 |
| Median price | $17.5117 |
| Average price | $17.5159 |
| Largest weekly change | -15.7% (Dec 17, 2025) |
| Weeks tracked | 101 |
| Tracking since | Sep 18, 2024 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of EVEROLIMUS 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for EVEROLIMUS 5 MG TABLET, manufactured by Hikma Pharmaceuticals USA Inc., is $14.7708 per EA (NDC 00054048113), effective Aug 19, 2026.
How has the price of EVEROLIMUS 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for EVEROLIMUS 5 MG TABLET has declined 27.5%. It has been tracked across 101 weekly CMS publications since Sep 18, 2024.
What are the highest and lowest recorded NADAC prices for EVEROLIMUS 5 MG TABLET?
Since Sep 18, 2024, the NADAC for EVEROLIMUS 5 MG TABLET has ranged from a low of $14.7708 (Dec 17, 2025) to a high of $23.3127 (Jan 15, 2025), with a median of $17.5117 per EA.
Are there cheaper alternatives to EVEROLIMUS 5 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as EVEROLIMUS 5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures EVEROLIMUS 5 MG TABLET?
EVEROLIMUS 5 MG TABLET (NDC 00054048113) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.